(RKLB) Rocket Lab USA - Overview
Stock: Launch Services, Spacecraft Components, Small Rockets, Constellation Management
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 97.1% |
| Relative Tail Risk | -8.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 123.25 |
| Character TTM | |
|---|---|
| Beta | 2.211 |
| Beta Downside | 2.076 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.49% |
| CAGR/Max DD | 2.70 |
Description: RKLB Rocket Lab USA December 17, 2025
Rocket Lab Corporation (NASDAQ:RKLB) is a U.S.-based space launch and spacecraft systems provider that operates in North America, Japan, and globally. It offers end-to-end services-including launch operations, spacecraft design, component manufacturing, on-orbit management, and constellation oversight-while producing its own small-launch vehicle, Electron, and developing the larger-capacity Neutron rocket for constellation deployment, interplanetary missions, and potential human spaceflight.
Key recent metrics: in FY 2023 the company generated roughly $224 million in revenue and completed 30+ dedicated launches, reflecting a ~15% year-over-year increase in launch cadence. The small-sat launch market is expanding at an estimated 12-15% CAGR, driven by the proliferation of LEO broadband constellations and government demand for rapid, responsive access to space. Rocket Lab’s Neutron vehicle, slated for a first flight in 2025, is positioned to capture a share of the emerging medium-class launch segment, competing directly with SpaceX’s Falcon 9 rideshare slots and emerging European providers.
For a deeper dive into Rocket Lab’s valuation metrics and peer comparison, the ValueRay platform offers a concise, data-rich overview.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -197.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA 2.12 > 1.0 |
| NWC/Revenue: 162.7% < 20% (prev 117.2%; Δ 45.48% < -1%) |
| CFO/TA -0.05 > 3% & CFO -103.4m > Net Income -197.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (528.7m) vs 12m ago 6.23% < -2% |
| Gross Margin: 31.70% > 18% (prev 0.26%; Δ 3144 % > 0.5%) |
| Asset Turnover: 32.87% > 50% (prev 31.55%; Δ 1.31% > 0%) |
| Interest Coverage Ratio: -31.21 > 6 (EBITDA TTM -190.4m / Interest Expense TTM 7.33m) |
Altman Z'' -0.73
| A: 0.41 (Total Current Assets 1.32b - Total Current Liabilities 414.5m) / Total Assets 2.22b |
| B: -0.43 (Retained Earnings -959.0m / Total Assets 2.22b) |
| C: -0.14 (EBIT TTM -228.6m / Avg Total Assets 1.69b) |
| D: -1.02 (Book Value of Equity -961.0m / Total Liabilities 940.4m) |
| Altman-Z'' Score: -0.73 = B |
Beneish M -2.75
| DSRI: 0.95 (Receivables 120.6m/83.0m, Revenue 554.5m/363.8m) |
| GMI: 0.82 (GM 31.70% / 26.06%) |
| AQI: 1.24 (AQ_t 0.24 / AQ_t-1 0.19) |
| SGI: 1.52 (Revenue 554.5m / 363.8m) |
| TATA: -0.04 (NI -197.6m - CFO -103.4m) / TA 2.22b) |
| Beneish M-Score: -2.75 (Cap -4..+1) = A |
What is the price of RKLB shares?
Over the past week, the price has changed by -9.68%, over one month by -15.94%, over three months by +45.78% and over the past year by +161.27%.
Is RKLB a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RKLB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 84 | 16.1% |
| Analysts Target Price | 84 | 16.1% |
| ValueRay Target Price | 88.5 | 22.4% |
RKLB Fundamental Data Overview February 02, 2026
P/B = 35.7277
Revenue TTM = 554.5m USD
EBIT TTM = -228.6m USD
EBITDA TTM = -190.4m USD
Long Term Debt = 398.3m USD (from longTermDebt, last quarter)
Short Term Debt = 17.1m USD (from shortTermDebt, last quarter)
Debt = 516.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -291.3m USD (from netDebt column, last quarter)
Enterprise Value = 42.31b USD (42.77b + Debt 516.6m - CCE 976.7m)
Interest Coverage Ratio = -31.21 (Ebit TTM -228.6m / Interest Expense TTM 7.33m)
EV/FCF = -182.7x (Enterprise Value 42.31b / FCF TTM -231.6m)
FCF Yield = -0.55% (FCF TTM -231.6m / Enterprise Value 42.31b)
FCF Margin = -41.76% (FCF TTM -231.6m / Revenue TTM 554.5m)
Net Margin = -35.64% (Net Income TTM -197.6m / Revenue TTM 554.5m)
Gross Margin = 31.70% ((Revenue TTM 554.5m - Cost of Revenue TTM 378.8m) / Revenue TTM)
Gross Margin QoQ = 36.96% (prev 32.10%)
Tobins Q-Ratio = 19.05 (Enterprise Value 42.31b / Total Assets 2.22b)
Interest Expense / Debt = 0.11% (Interest Expense 590.0k / Debt 516.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -180.6m (EBIT -228.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.18 (Total Current Assets 1.32b / Total Current Liabilities 414.5m)
Debt / Equity = 0.40 (Debt 516.6m / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = 1.53 (negative EBITDA) (Net Debt -291.3m / EBITDA -190.4m)
Debt / FCF = 1.26 (negative FCF - burning cash) (Net Debt -291.3m / FCF TTM -231.6m)
Total Stockholder Equity = 695.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.71% (Net Income -197.6m / Total Assets 2.22b)
RoE = -28.40% (Net Income TTM -197.6m / Total Stockholder Equity 695.8m)
RoCE = -20.89% (EBIT -228.6m / Capital Employed (Equity 695.8m + L.T.Debt 398.3m))
RoIC = -16.27% (negative operating profit) (NOPAT -180.6m / Invested Capital 1.11b)
WACC = 13.89% (E(42.77b)/V(43.29b) * Re(14.06%) + D(516.6m)/V(43.29b) * Rd(0.11%) * (1-Tc(0.21)))
Discount Rate = 14.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.20%
Fair Price DCF = unknown (Cash Flow -231.6m)
EPS Correlation: -44.76 | EPS CAGR: -8.06% | SUE: 1.86 | # QB: 1
Revenue Correlation: 94.61 | Revenue CAGR: 58.64% | SUE: 0.97 | # QB: 2
EPS next Quarter (2026-03-31): EPS=-0.08 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=6
EPS next Year (2026-12-31): EPS=-0.22 | Chg30d=+0.018 | Revisions Net=+0 | Growth EPS=+42.3% | Growth Revenue=+50.1%